Bio Passport Price

BioPassport Token (BIOT) is a cryptocurrency launched in 2020. It sits squarely at the intersection of decentralized identity and digital health, issued as an ERC-20 asset on Ethereum.

The protocol underpins a telehealth platform that facilitates remote monitoring of chronic and infectious conditions — from post-COVID syndrome to lung cancer screening and atopic allergy test kit distribution. Data silos and fragmented patient records are the structural friction it targets. The ecosystem combines cryptographic identity management with secure, on-demand medical diagnostics.

BioPassport Token operates on the Ethereum network. Its entire smart contract suite executes within the Ethereum Virtual Machine, inheriting the base-layer security of a globally distributed validator set.

As a standard ERC-20 token, BIOT relies on Ethereum’s proof-of-work legacy infrastructure and subsequent proof-of-stake finality. The token contract, verified on Etherscan at 0xc07a150ecadf2cc352f5586396e344a6b17625eb, exposes open-source Solidity code. Block times and gas mechanics are those of the host chain, with no additional consensus layer.

The project materialized in the autumn of 2020 as global healthcare systems strained under pandemic pressures. Its launch coincided with an acute demand for decentralized, patient-controlled health data repositories. The initiative did not orbit a single public figure; rather, a distributed team of developers and medical technologists assembled the core architecture, publishing the whitepaper and GitHub repository without fanfare.

The long-term objective is a radical overhaul of medical data governance. Instead of institutional gatekeepers hoarding patient records, the protocol pushes sovereignty to the individual, enabling tamper-proof, patient-initiated data sharing. That architectural choice positions BIOT as a privacy-preserving data rail for clinical research, insurance underwriting, and cross-border health coordination.

Within the application layer, BIOT tokens route access to diagnostic workflows. Patients spend tokens to order at-home test kits, unlock AI-driven remote screening modules, or compensate telehealth physicians. On the data-sharing side, third parties — research labs, pharmaceutical firms — must acquire BIOT to submit data access requests, which patients accept via smart contract-automated consent receipts.

A patient holding BIOT can directly purchase a lung cancer biomarker kit without intermediation, then upload encrypted results to a personal vault. That same token balance grants entry to video consultations with specialists who cross-reference on-chain health records. In research contexts, token holders may opt into anonymized data pools where smart contracts distribute micropayments for each consented data query.

BioPassport Token has a maximum supply of 8,800,000,000 tokens. Currently, 8,799,999,998 are in circulation. Over the past 24 hours, trading volume reached $74,473.94 across seven active markets. With a market capitalization of $3,147,844.24, BioPassport Token ranks #1,396 among all cryptocurrencies.